Burkina Faso begins vaccinations in RTS,S Phase 3 trial
Nanoro is one of 11 trial sites in seven African countries
Read more »
Partnering with us
We are pursuing a range of vaccine development approaches with an expanding circle of industry, academic, and government partners.
Our portfolio
MVI maintains a diverse portfolio of projects, including preclinical feasibility studies, translational projects, and one advanced clinical project.
What we do and how we do it
MVI provides funding and technical support to partners worldwide to accelerate the development of malaria vaccines. MVI also works to ensure that malaria vaccines will reach those who need them.
Photo: MVI/ David Poland

